Long-term outcomes of high-risk percutaneous coronary interventions under extracorporeal membrane oxygenation support: An observational study

doi:10.12998/wjcc.v10.i16.5266

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4466)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

225

WORD

HTML

2407

Tables (1-3)

623

Sum=3341

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

292

Download

808

Sum=1100

Jun 6, 2022 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Cases. Jun 6, 2022; 10(16): 5266-5274
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5266

Table 1 Baseline clinical features

Features	Cases (n = 61)
Age (yr)	74 (64-79)
Male, n (%)	45 (73.8)
BMI (kg/m²)	25.0 ± 3.4
Diabetes mellitus, n (%)	30 (49.2)
Hypertension, n (%)	40 (65.6)
Dyslipidemia, n (%)	8 (13.1)
Current smoking, n (%)	20 (32.8)
Previous MI, n (%)	20 (32.8)
Previous PCI, n (%)	9 (14.8)
Previous CABG, n (%)	11 (18.0)
Previous stroke, n (%)	16 (26.2)
COPD, n (%)	3 (4.9)
CRF, n (%)	30 (49.2)
Peripheral vascular disease, n (%)	3 (4.9)
LVEF	42 (32-49)
LVEF ≤ 35%, n (%)	20 (32.8)
Clinical presentation STEMI, n (%)	18 (29.5)
NSTEMI, n (%)	11 (18.0)
UA, n (%)	32 (52.5)
¹SYNTAX score	43.2 ± 10.0
EuroSCORE	12 (10-15)
GRACE score	163 (145-195)

¹SYNTAX score was only calculated in patients without prior CABG, n = 50.

BMI: Body mass index; MI: Myocardial infarction; PCI: Percutaneous coronary intervention; CABG: Coronary artery bypass graft; COPD: Chronic obstructive pulmonary disease; CRF: Chronic renal failure; LVEF: Left ventricular ejection fraction; STEMI: ST-elevation myocardial infarction; NSTEMI: Non-ST-elevation myocardial infarction; UA: Unstable angina.

Table 2 Procedural characteristics

Characteristics	Patients (n = 61)
IABP, n (%)	25 (41.0)
Successful PCI, n (%)	57 (93.4)
Number of DESs	2 (1-3)
Duration of VA-ECMO (h)	1.6 (1.2-2.4)
Dosage of contrast (mL)	120 (95-161)
Residual SYNTAX score	18.9 ± 13.1
Intraoperative hypotension, n (%)	15 (24.6)

IABP: Intra-aortic balloon pump; PCI: Percutaneous coronary intervention; DESs: Drug-eluting stents; VA-ECMO: Venoarterial extracorporeal membrane oxygenation.

Table 3 Clinical outcomes, n (%)

Characteristics	Patients (n = 61)
In-hospital mortality	14 (23.0)
Cardiac shock	10 (16.4)
Septic shock	3 (4.9)
Early stent thrombosis	1 (1.6)
Postoperative cerebral infarction	4 (6.6)
One-year mortality	19 (31.1)
Overall mortality	33 (54.1)
Cardiac death	18 (29.5)
Sepsis	7 (11.5)
Hemorrhage	1 (1.6)
Malignant tumor	3 (4.9)
Fracture	2 (3.4)
End-stage renal disease	1 (1.6)
Aplastic anemia	1 (1.6)

Citation: Huang YX, Xu ZM, Zhao L, Cao Y, Chen Y, Qiu YG, Liu YM, Zhang PY, He JC, Li TC. Long-term outcomes of high-risk percutaneous coronary interventions under extracorporeal membrane oxygenation support: An observational study. World J Clin Cases 2022; 10(16): 5266-5274
URL: https://www.wjgnet.com/2307-8960/full/v10/i16/5266.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i16.5266